Key Dates

Related Announcements

• August 16, 2024 - Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed). See NOFO RFA-HD-25-003.

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that effective11/4/2024 the National Heart, Lung, and Blood Institute (NHLBI) will participate in RFA-HD-25-003 "Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)".

The following text in bold and italics has been added to reflect NHLBI's participation:

Part 1. Overview Information

Components of Participating Organizations

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Heart, Lung, and Blood Institute (NHLBI)

Assistance Listing Number(s)

93.865, 93.279, 93.242, 93.855, 93.121, 93.837, 93.838, 93.840, 93.233

Section II. Award Information

Funds Available and Anticipated Number of Awards

NHLBI intends to commit approximately $1 million per year to support the PHACS program.

All other aspects of the NOFO remain the same.

Inquiries

Please direct all inquiries regarding this Notice to:

Scientific/Research Contact(s)

Elizabeth Barnett Pathak, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-6585
Email: [email protected] 

Financial/Grants Management Contact(s)

Lynn Rundhaugen
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-480-4546
Email: [email protected]